Gordon MacGregor

8.0k citations

32 papers · 649 indexed · h-index 12

Impact in

Pulmonary and Respiratory Medicine top 10%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inhalation and Respiratory Drug Delivery
- Tracheal and airway disorders
Molecular Medicine

Papers in ⓘ

Pulmonary and Respiratory Medicine 23
- Cystic Fibrosis Research Advances 21
- Neonatal Respiratory Health Research 6
- Tracheal and airway disorders 3
Epidemiology 4
- Respiratory viral infections research 3

Co-authors: M. Imrie (3 shared papers)A P Greening (3 shared papers)David J. Porteous (3 shared papers)J. Alastair Innes (2 shared papers)Robert D. Gray (2 shared papers)A. Christopher Boyd (2 shared papers)Donald Noble (1 shared paper)Maria H Dewar (1 shared paper)
Journals: Journal of Cystic Fibrosis (8 papers)PLoS ONE (2 papers)Value in Health (2 papers)American Journal of Respiratory and Critical Care Medicine (1 paper)Postgraduate Medical Journal (1 paper)
Partner nations: United Kingdom United States Canada

In The Last Decade

Gordon MacGregor

30 papers receiving 633 citations

Peers

Countries citing papers authored by Gordon MacGregor

Since Specialization

Citations

This map shows the geographic impact of Gordon MacGregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon MacGregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon MacGregor more than expected).

Fields of papers citing papers by Gordon MacGregor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon MacGregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon MacGregor. The network helps show where Gordon MacGregor may publish in the future.

Co-authors

The 25 scholars most cited alongside Gordon MacGregor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gordon MacGregor Line = papers co-authored together Gordon MacGregor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases American Journal of Respiratory and Critical Care Medicine ·Robert D. Gray, Gordon MacGregor, Donald Noble, M. Imrie, Maria H Dewar, A. Christopher Boyd, J. Alastair Innes, David J. Porteous, A P Greening	2008	145
2	Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del Journal of Cystic Fibrosis ·Andrea Lopez, Conor Daly, G. Vega-Hernández, Gordon MacGregor, Jaime Rubin	2023	69
3	A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease Molecular Pharmaceutics ·M. Pritchard, Lydia C. Powell, Georgina Menzies, Paul D. Lewis, Karl Hawkins, Chris J. Wright, Iolo Doull, Timothy R. Walsh, E. Onsøyen, Arne Dessen, Rolf Myrvold, Philip D. Rye, Astrid Hilde Myrset, Howard N.E. Stevens, Lee Ann Hodges, Gordon MacGregor, J. B. Neilly, Katja E. Hill, David W. Thomas	2016	64
4	Identification and characterisation of Staphylococcus aureus on low cost screen printed carbon electrodes using impedance spectroscopy Biosensors and Bioelectronics ·Andrew C. Ward, Aiden J. Hannah, Sara Kendrick, Nicholas P. Tucker, Gordon MacGregor, Patricia Connolly	2018	56
5	Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo Respiratory Research ·Uta Griesenbach, Chris Kitson, Escudero Sara Garcia, Raymond Farley, Charanjit Singh, Luci Somerton, Hazel Painter, R. Smith, Deborah R. Gill, Stephen C. Hyde, Yu‐Hua Chow, Jim Hu, Michael A. Gray, Mark R. Edbrooke, Varrie Ogilvie, Gordon MacGregor, Ronald K. Scheule, Seng H. Cheng, Natasha J. Caplen, Eric W.F.W. Alton	2006	49
6	Breath condensate ammonium is lower in children with chronic asthma European Respiratory Journal ·Gordon MacGregor, Samantha Ellis, James Andrews, M. Imrie, A.J Innes, A P Greening, Steve Cunningham	2005	41
7	Biomarkers for cystic fibrosis lung disease: Application of SELDI-TOF mass spectrometry to BAL fluid Journal of Cystic Fibrosis ·Gordon MacGregor, Robert D. Gray, Thomas N. Hilliard, M. Imrie, Alan Boyd, Eric W.F.W. Alton, Andrew Bush, Jane C. Davies, J. Alastair Innes, David J. Porteous, A P Greening	2008	36
8	T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis PLoS ONE ·Hannah Bayes, Stephen Bicknell, Gordon MacGregor, Tom Evans	2014	36
9	Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis Clinical and Translational Science ·J.S. Elborn, Alex Horsley, Gordon MacGregor, Diana Bilton, Ralph Grosswald, Sanjeev Ahuja, EB Springman	2016	35
10	Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study ERJ Open Research ·Silke van Koningsbruggen‐Rietschel, Jane C. Davies, Tacjana Pressler, Rainald Fischer, Gordon MacGregor, Scott H. Donaldson, Knut T. Smerud, Nils Meland, Jann Mortensen, Marie Øbro Fosbøl, D.G. Downey, Astrid Hilde Myrset, Hugo Flaten, Philip D. Rye	2020	25
11	Yoghurt biotherapy: contraindicated in immunosuppressed patients? Postgraduate Medical Journal ·Gordon MacGregor, Alexander Smith, B. Thakker, John Kinsella	2002	23
12	Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study BMC Pulmonary Medicine ·Scott C. Bell, Jochen G. Mainz, Gordon MacGregor, Susan Madge, Julie Macey, Moshe Fridman, Ellison Suthoff, S Narayanan, Nils Kinnman	2019	13
13	Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes Diabetes Therapy ·Gregory C. Jones, Zhou M. Chong, Jennifer Gilmour, Christine R. Matheson, Gordon MacGregor, Christopher Sainsbury	2016	10
14	Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial PLoS ONE ·Graham Devereux, Danielle Wrolstad, Stephen Bourke, Cori Daines, Simon Doe, Ryan H. Dougherty, Rose Franco, A.J Innes, Benjamin T. Kopp, Jorge Lascano, Daniel Layish, Gordon MacGregor, Lorna Murray, D. Peckham, V. Lucidi, Emma Lovie, Jennifer Robertson, Douglas Fraser‐Pitt, Deborah A. O′Neil	2020	9
15	Human-Specific Cystic Fibrosis Transmembrane Conductance Regulator Antibodies Detect In Vivo Gene Transfer to Ovine Airways American Journal of Respiratory Cell and Molecular Biology ·Heather Davidson, Gerry McLachlan, Abigail Wilson, A. Christopher Boyd, Ann Doherty, Gordon MacGregor, Lee Davies, Hazel Painter, Rebecca Coles, Stephen C. Hyde, Deborah R. Gill, Margarida D. Amaral, David Collie, David J. Porteous, Deborah Penque	2006	7
16	WS13.6 GLPG1837 in subjects with cystic fibrosis (CF) and the G551D mutation: results from a phase II study (SAPHIRA1) Journal of Cystic Fibrosis ·Jane C. Davies, S.C. Bell, Silke van Koningsbruggen‐Rietschel, E.F. McKone, Gordon MacGregor, Pavel Dřevı́nek, Katja Conrath, Herman de Kock, Charlotte Gesson, D. Kanters, O. Van de Steen	2017	4
17	126 A phase 1 clinical study of CTX-4430 in cystic fibrosis patients Journal of Cystic Fibrosis ·Eric B. Springman, Ralph Grosswald, E. Philpot, Gordon MacGregor, A. Horsley, Diana Bilton, J. P. Stewart, J.S. Elborn	2015	4
18	Ivacaftor: Five‐year outcomes in the West of Scotland cystic fibrosis population The Clinical Respiratory Journal ·Yasmin Al‐Din, Carol Dryden, Gordon MacGregor, David Young, Cristina Coelho	2023	3
19	A Pharmacological Review of Calcitonin Gene-Related Peptide Biologics and Future Use for Chronic Pain Cureus ·David A. Cooper, William D. Laidig, Alexandra Sappington, Gordon MacGregor	2023	3
20	Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation European Journal of Hospital Pharmacy ·I. Paterson, Chris Johnson, Gordon MacGregor	2021	3

About Gordon MacGregor

Gordon MacGregor is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Physiology, Infectious Diseases and Immunology, having authored 32 papers that have together received 649 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (21 papers), Neonatal Respiratory Health Research (6 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Tracheal and airway disorders (3 papers), Nematode management and characterization studies (3 papers), Pediatric health and respiratory diseases (3 papers), Respiratory viral infections research (3 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (379 citations), Molecular Medicine (25 citations), Emergency Medical Services (34 citations), Physiology (100 citations) and Microbiology (23 citations). Gordon MacGregor has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include M. Imrie, A P Greening, David J. Porteous, J. Alastair Innes, Robert D. Gray, A. Christopher Boyd, Donald Noble, Maria H Dewar, Jaime Rubin and Conor Daly. Their work appears in journals such as Journal of Cystic Fibrosis, PLoS ONE, Value in Health, American Journal of Respiratory and Critical Care Medicine and Postgraduate Medical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact